Domů › Rakovina žaludku › Kalifornie › Los Angeles
Klinické studie Rakovina žaludku v Los Angeles, CA
22 studií pro Rakovina žaludku hledá účastníky v lokalitách v Los Angeles a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Probíhá náborFáze 1
- University of California - Los Angeles, Los Angeles
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Probíhá náborFáze 2/3
- USC/Norris Comprehensive Cancer Center, Los Angeles
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Probíhá náborFáze 3
- UCLA Health, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Probíhá náborFáze 1/2
- University of Southern California, Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Probíhá náborFáze 2
- Research Site, Los Angeles
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Probíhá náborFáze 3
- UCLA, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Probíhá náborFáze 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Probíhá náborFáze 1
- ULCA, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- The Angeles Clinic and Research Institute, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Probíhá náborFáze 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Probíhá náborFáze 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Probíhá náborFáze 1
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Probíhá náborFáze 1
- Start Lacn, Los Angeles
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Probíhá náborFáze 2
- Research Site, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Probíhá nábor
- Oncology Institute for Hope and Innovation, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Probíhá nábor
- Cedars-Sinai Medical Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Southern California, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Probíhá náborFáze 1/2
- Cedars Sinai Medical Center, Los Angeles
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Probíhá náborFáze 4
- Cedars-Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
Probíhá náborFáze 1
- University of Southern California, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Probíhá náborFáze 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Studie Rakovina žaludku v jiných městech
- Houston, TX42 studií
- Boston, MA32 studií
- New York City, NY31 studií
- Nashville, TN28 studií
- Baldwin Park, CA22 studií
- Arlington, VA20 studií
- Dallas, TX19 studií
- San Antonio, TX19 studií
- St. Louis, MO18 studií
- Grand Rapids, MI18 studií
- Washington, DC16 studií
- Chicago, IL16 studií
Další studie v Los Angeles
- Nemalobuněčný plicní karcinom87 studií
- Rakovina (všechny typy)74 studií
- Rakovina prsu73 studií
- Rakovina prostaty61 studií
- Kolorektální karcinom59 studií
- Metastatický karcinom57 studií
- Rakovina vaječníků50 studií
- Rakovina plic45 studií
- Squamózní buněčný karcinom hlavy a krku42 studií
- Rakovina slinivky břišní35 studií
- Rakovina endometria34 studií
- Melanom34 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.